Contract Management Branch, National Institute of Neurological Disorders and Stroke, NIH, Federal Building, Room 901, 7550 Wisconsin Avenue, MSC 9190, Bethesda, Maryland 20892-9190

A -- SEIZURE MODELS TO IDENTIFY NEW COMPOUNDS FOR EPILEPSY SOL 98-RFI-02 DUE 081998 POC Raina Cervantes, Contracting Officer, tel #(301) 496-1813, fax #(301) 402-4225 E-MAIL: Laurie Leonard, ll44s@nih.gov. -- The NINDS is seeking to identify sources who have developed or who have the expertise and capability of developing seizure models, based on current and previous work, that can be used in identifying new chemical entities for the treatment of therapy-resistant epilepsy or recurrent seizures. These seizure models can utilize either in vivo or in vitro technologies. Interested organizations are asked to submit the following information to demonstrate both their organizational and personnel experience and capabilities: 1) For sources who have a seizure model, provide a description of the technology (seizure model) and a summary of the experimental data showing drug effects in the technology. For sources having the expertise and capability of developing a seizure model, provide a description of a proposed model along with supporting evidence of previous experience in developing seizure models. The documentation could be in the form of scientific publications or reports. 2) Provide documentation to demonstrate staff/personnel knowledge, experience and expertise in developing seizure models for drug discovery. 3) Describe the existing animal and laboratory facilities and equipment needed to develop a seizure model; and 4) Include other specific and pertinent information as it would pertain to your ability and expertise in this area. -- Interested organizations should submit a capability statement of approximately ten (10) pages addressing the information requested above and detailing ability to perform all aspects of the effort described herein. Responses will be reviewed only by NIH personnel and will be held in a confidential manner. All proprietary information should be so marked and will be protected. -- This announcement is a Request for Information (RFI). The purpose of this RFI is to identify potential sources that may be interested and capable of developing new seizure models. The Government does not intend to award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or the Government's use of such information. Acknowledgment of receipt of responses will not be made and respondents will not be notified of the results of the evaluation of information submitted. However, should such a requirement materialize, no basis for claims against the Government shall arise as a result of a response to this synopsis or the government's use of such information as part of the evaluation process or in developing specifications for any subsequent requirement. This requirement is listed under Standard Industrial Classification SIC Code 8731. All respondents are asked to indicate the type and size of your business organization, e.g., Large Business, Small Business, Small Disadvantaged Business, Women-Owned Business, 8(a), Historically Black College or University/Minority Institution (HBCU/MI), educational institution, profit/non-profit hospital, or other nonprofit organization, in their response. Responses should be identified with NINDS No. 98-RFI-02 and submitted within 45 days from the date of this announcement. Please submit three (3) copies of your response to the attention of: Raina Cervantes, Contracting Officer, Contracts Management Branch, National Institute of Neurological Disorders and Stroke, NIH, Federal Building, Room 901, 7550 Wisconsin Avenue, MSC 9190, Bethesda, Maryland 20892-9190. Facsimile and E-mail responses sent to ec58q@nih.gov shall also be accepted. Posted 07/01/98. (0182)

Loren Data Corp. http://www.ld.com (SYN# 0007 19980706\A-0007.SOL)